Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludes
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
EurekAlert!4d
Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study proves
The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...
The Financial Express3d
Diabetes if not managed can lead to limb amputation-Know how to prevent it
Small cuts or blisters should be cleaned, treated, and closely monitored until healed. Any signs of infection should be ...
Onlymyhealth1d
Diabetes: How It Harms Your Heart, Kidneys, Eyes, And More Over Time
Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
GlobalData on MSN8d
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
ots9d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neur
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...
The Nassau Guardian5d
Diabetes and your feet
If there is an infection, it will take a long time to treat because there is not enough blood ... This damage to the nerves ...
Year-long action plan to combat diabetes to be launched on World Diabetes Day
A year-long integrated, intensive action plan is being chalked out to augment all diabetes control programmes in the State. The programme, which will be kicked off on November 14, World Diabetes Day, ...
pharmaphorum3d
Helixmith starts new trial of diabetic neuropathy gene therapy
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN ... At the moment treatment is limited to drugs like gabapentin and ...